Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 518

1.

Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R.

Ann Intern Med. 1998 Jun 15;128(12 Pt 1):982-8.

PMID:
9625684
2.
3.
4.
5.

Long-term effect of ACE inhibition on development of nephropathy in diabetes mellitus type II.

Ravid M, Savin H, Jutrin I, Bental T, Lang R, Lishner M.

Kidney Int Suppl. 1994 Feb;45:S161-4.

PMID:
8158887
7.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

8.

Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects.

Ahmad J, Shafique S, Abidi SM, Parwez I.

Diabetes Res Clin Pract. 2003 May;60(2):131-8.

PMID:
12706322
9.

Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.

Diabetes Care. 1998 Jan;21(1):104-10.

PMID:
9538979
10.

Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.

Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, Raffaele J, Tsalamandris C.

Am J Kidney Dis. 2001 May;37(5):890-9.

PMID:
11325669
11.

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R.

Arch Intern Med. 1998 May 11;158(9):998-1004.

PMID:
9588433
12.
13.

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

Estacio RO, Jeffers BW, Gifford N, Schrier RW.

Diabetes Care. 2000 Apr;23 Suppl 2:B54-64.

PMID:
10860192
16.

Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.

Heinemann L, Janicke I, Bender R, Berger M, Sawicki PT.

Horm Metab Res. 1996 Oct;28(10):549-52.

PMID:
8934214
18.

Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized study.

Sano T, Hotta N, Kawamura T, Matsumae H, Chaya S, Sasaki H, Nakayama M, Hara T, Matsuo S, Sakamoto N.

Diabet Med. 1996 Feb;13(2):120-4.

PMID:
8641115
19.

Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial.

Zandbergen AA, Baggen MG, Lamberts SW, Bootsma AH, de Zeeuw D, Ouwendijk RJ.

Ann Intern Med. 2003 Jul 15;139(2):90-6.

PMID:
12859158
20.

Supplemental Content

Support Center